ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

FDA’s Jane Henney

February 11, 1994

In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request

October 6, 1978

In Brief: GM Cancer Research Foundation Awards Three Prizes to Five Cancer Researchers

May 5, 2000

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

October 26, 2012

Groups’ Growth, Impact Shown by Five-Year Data

March 3, 1978